Skip to content
★ Sign in to follow
JM

Jan M. Van Tornout

Directeur Médical
Tyme Technologies, Inc.
Total declarations
5
Company
1
▲ Purchases (5 ops.)
€5,881
▼ Sales (0 ops.)
—

Latest filing published 22 Feb 2022 for Tyme Technologies, INC., €2,222.

Filing timeline

BuySale
Jan M. Van Tornout

Insider track record

Disclosed buys
5
Disclosed sells
0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Jan M. Van Tornout: trading record in brief

Jan M. Van Tornout is a declared insider of Tyme Technologies, Inc. (senior executive), with filings sourced from SEC (Form 4). In total, 5 filings cover trades dated from 5 April 2021 to 17 February 2022.

The open-market record is one-sided, with 5 purchases worth €5,881 and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2022: 1 purchase and no sales on the market.

The median purchase comes to €895. On 1 out of 5 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

On 22 February 2022 came the latest disclosure, an open-market purchase for €2,222 in Tyme Technologies, Inc. Filings reach the SEC (Form 4) feed a median of 7 days after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Jan M. Van Tornout

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ▲
    Acting Chief Medical OfficerExecutivesTyme Technologies, Inc.
    2,528 USD36SEC
    7,022 shares@ US$0.3671.3% of flowCommon StockSEC:0000899243-22-007169:0
    Canonical exit: 18 May 2022 (T+90)
  • ▲
    Acting Chief Medical OfficerExecutivesTyme Technologies, Inc.
    1,050 USD18SEC
    1,000 shares@ US$1.0528.7% of flowCommon StockSEC:0000899243-21-033112:0
    Canonical exit: 10 Nov 2021 (T+90)

2 of 2 declarations